ALPMY
Price
$9.66
Change
-$0.21 (-2.13%)
Updated
Jun 5 closing price
Capitalization
26.55B
54 days until earnings call
DSNKY
Price
$24.55
Change
-$1.31 (-5.07%)
Updated
Jun 5 closing price
Capitalization
59.21B
Interact to see
Advertisement

ALPMY vs DSNKY

Header iconALPMY vs DSNKY Comparison
Open Charts ALPMY vs DSNKYBanner chart's image
Astellas Pharma
Price$9.66
Change-$0.21 (-2.13%)
Volume$181.29K
Capitalization26.55B
Daiichi Sankyo
Price$24.55
Change-$1.31 (-5.07%)
Volume$273.05K
Capitalization59.21B
ALPMY vs DSNKY Comparison Chart
Loading...
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMY vs. DSNKY commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMY is a Buy and DSNKY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ALPMY: $9.66 vs. DSNKY: $24.55)
Brand notoriety: ALPMY and DSNKY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMY: 95% vs. DSNKY: 84%
Market capitalization -- ALPMY: $26.55B vs. DSNKY: $59.21B
ALPMY [@Pharmaceuticals: Major] is valued at $26.55B. DSNKY’s [@Pharmaceuticals: Major] market capitalization is $59.21B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMY’s FA Score shows that 1 FA rating(s) are green whileDSNKY’s FA Score has 1 green FA rating(s).

  • ALPMY’s FA Score: 1 green, 4 red.
  • DSNKY’s FA Score: 1 green, 4 red.
According to our system of comparison, DSNKY is a better buy in the long-term than ALPMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMY’s TA Score shows that 8 TA indicator(s) are bullish while DSNKY’s TA Score has 5 bullish TA indicator(s).

  • ALPMY’s TA Score: 8 bullish, 2 bearish.
  • DSNKY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALPMY is a better buy in the short-term than DSNKY.

Price Growth

ALPMY (@Pharmaceuticals: Major) experienced а -0.41% price change this week, while DSNKY (@Pharmaceuticals: Major) price change was -9.23% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.15%. For the same industry, the average monthly price growth was +3.71%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

ALPMY is expected to report earnings on Jul 30, 2025.

DSNKY is expected to report earnings on Apr 25, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.15% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSNKY($59.2B) has a higher market cap than ALPMY($26.6B). DSNKY has higher P/E ratio than ALPMY: DSNKY (75.76) vs ALPMY (37.59). ALPMY YTD gains are higher at: 0.000 vs. DSNKY (-10.040). ALPMY has higher annual earnings (EBITDA): 247B vs. DSNKY (203B). DSNKY has more cash in the bank: 825B vs. ALPMY (397B). ALPMY has less debt than DSNKY: ALPMY (30B) vs DSNKY (143B). ALPMY has higher revenues than DSNKY: ALPMY (1.52T) vs DSNKY (1.28T).
ALPMYDSNKYALPMY / DSNKY
Capitalization26.6B59.2B45%
EBITDA247B203B122%
Gain YTD0.000-10.040-
P/E Ratio37.5975.7650%
Revenue1.52T1.28T119%
Total Cash397B825B48%
Total Debt30B143B21%
FUNDAMENTALS RATINGS
ALPMY vs DSNKY: Fundamental Ratings
ALPMY
DSNKY
OUTLOOK RATING
1..100
571
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
93
Overvalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
1002
PRICE GROWTH RATING
1..100
7360
P/E GROWTH RATING
1..100
9897
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMY's Valuation (4) in the null industry is significantly better than the same rating for DSNKY (93). This means that ALPMY’s stock grew significantly faster than DSNKY’s over the last 12 months.

DSNKY's Profit vs Risk Rating (90) in the null industry is in the same range as ALPMY (100). This means that DSNKY’s stock grew similarly to ALPMY’s over the last 12 months.

DSNKY's SMR Rating (2) in the null industry is significantly better than the same rating for ALPMY (100). This means that DSNKY’s stock grew significantly faster than ALPMY’s over the last 12 months.

DSNKY's Price Growth Rating (60) in the null industry is in the same range as ALPMY (73). This means that DSNKY’s stock grew similarly to ALPMY’s over the last 12 months.

DSNKY's P/E Growth Rating (97) in the null industry is in the same range as ALPMY (98). This means that DSNKY’s stock grew similarly to ALPMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMYDSNKY
RSI
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
51%
Bearish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 10 days ago
71%
Declines
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
71%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
65%
Aroon
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFEMX31.620.17
+0.54%
DFA Emerging Markets I
ORSAX14.09N/A
N/A
North Square Dynamic Sm Cp A
LGPSX36.08N/A
N/A
ProFunds Large Cap Growth Svc
FIMVX27.21N/A
N/A
Fidelity Mid Cap Value Index
RISSX13.60N/A
N/A
RBC International Small Cap Equity A

ALPMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMY has been loosely correlated with ALPMF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMY jumps, then ALPMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMY
1D Price
Change %
ALPMY100%
-2.13%
ALPMF - ALPMY
38%
Loosely correlated
N/A
OPHLY - ALPMY
33%
Loosely correlated
-1.13%
CHGCY - ALPMY
22%
Poorly correlated
-1.35%
DSNKY - ALPMY
21%
Poorly correlated
-5.07%
OTSKY - ALPMY
20%
Poorly correlated
-0.99%
More

DSNKY and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSNKY has been loosely correlated with CHGCY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DSNKY jumps, then CHGCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSNKY
1D Price
Change %
DSNKY100%
-5.07%
CHGCY - DSNKY
38%
Loosely correlated
-1.35%
OTSKY - DSNKY
37%
Loosely correlated
-0.99%
DSKYF - DSNKY
34%
Loosely correlated
-7.91%
BIIB - DSNKY
23%
Poorly correlated
-1.14%
ALPMY - DSNKY
21%
Poorly correlated
-2.13%
More